For many years, medical devices played second fiddle to medicines in the pharmaceutical industry. Their role was to facilitate the use of the “star” products, the drugs.
Together, Nanoform and Celanese will investigate the potential for enabling next-generation drug delivery devices by combining Nanoform’s nanoparticle platform technologies and Celanese’s VitalDose® EVA copolymer delivery technology.
The second fully virtual Bio Integrates Conference surpassed expectations, with over 450 delegates attending animated keynote speaker sessions and panel debates, addressing this year’s conference themes of Connection, Projection and Reflection.
The logistics challenges of the past few months are countless – from limited spaces on aircraft, reduced routes, and unpredictable delays at main hubs to ferry terminal ques and post-Brexit customs delays.
Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced the completion and final results of its clinical study.